Cancer targeted and tissue specific gene therapy of in vivo hepatocellular carcinoma model by hTERT-targeting trans-splicing ribozyme and liver specific promoter

被引：0
|
作者：
Jeong, Jin S.
Han, Sang Y.
Song, Min S.
Lee, Seong W.
Kim, In H.
机构：
[1] Dong A Univ Coll Med, Med Ctr Canc Mol Therapy, Pusan 411769, South Korea
[2] Dankook Univ, Inst Nanosensor & Biotechnol, Seoul, South Korea
[3] Natl Canc Ctr, Res Inst Hosp, Goyang, Gyeonggi, South Korea
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
632
引用
收藏
页码：519A / 519A
页数：1
相关论文
共 29 条
  • [21] In Vitro and In Vivo Tissue Specific Cytotoxicity of Gastric Cancer Cells Resulting from CD:UPRT/5-FC Gene Therapy System Driven by hTERT Promoter
    Liu, Ting
    Cao, Weijun
    He, Xiaowen
    Zhang, Guowen
    Leng, Aiming
    Liu, Hui
    Ye, Ling
    Zhang, Guiying
    Chen, Yuxiang
    ADVANCED SCIENCE LETTERS, 2011, 4 (01) : 12 - 17
  • [22] Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes
    Hu, Yurong
    Shen, Yingying
    Ji, Baofang
    Yin, Shasha
    Ren, Xueling
    Chen, Tingting
    Ma, Yue
    Zhang, Zhenzhong
    Zhang, Yun
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 78 (03) : 320 - 325
  • [23] Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: A promising implication of telomerase-dependent targeted cancer gene therapy
    Murofushi, Yoshiteru
    Nagano, Satoshi
    Kamizono, Junichi
    Takahashi, Tomoyuki
    Fujiwara, Hisayoshi
    Komiya, Setsuro
    Matsuishi, Toyojiro
    Kosai, Ken-Ichiro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (03) : 681 - 688
  • [24] A new in vitro model of specific targeting therapy of cancer: Retargeting of PWM-LAK cells with bispecific antibodies greatly enhances cytotoxicity to hepatocellular carcinoma
    Saijyo, S
    Kudo, T
    Katayose, Y
    Saeki, H
    Chiba, N
    Suzuki, M
    Tominaga, T
    Matsuno, S
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 178 (02) : 113 - 127
  • [25] Characterization of an orthotopic rat colon cancer liver metastasis (CCLM) model to test clinically relevant tissue-specific gene therapy
    Shinozake, K
    Woo, S
    Yio, X
    Itzkowitz, S
    GASTROENTEROLOGY, 2002, 122 (04) : A235 - A235
  • [26] Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model
    M Y Gabril
    T Onita
    P G Ji
    H Sakai
    F L Chan
    J Koropatnick
    J L Chin
    M Moussa
    J W Xuan
    Gene Therapy, 2002, 9 : 1589 - 1599
  • [27] Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model
    Gabril, MY
    Onita, T
    Ji, PG
    Sakai, H
    Chan, FL
    Koropatnick, J
    Chin, J
    Moussa, M
    Xuan, JW
    GENE THERAPY, 2002, 9 (23) : 1589 - 1599
  • [28] Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo
    Lin Fang
    Li Shanqu
    Gao Ping
    He Ting
    Wang Xi
    Dong Ke
    Long Min
    Wei Junxia
    Zhang Huizhong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 1079 - 1087
  • [29] Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo
    Lin Fang
    Li Shanqu
    Gao Ping
    He Ting
    Wang Xi
    Dong Ke
    Long Min
    Wei Junxia
    Zhang Huizhong
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1079 - 1087
123